Contact
Please use this form to send email to PR contact of this press release:
ContraVir Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
TO:
Please use this form to send email to PR contact of this press release:
ContraVir Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
TO: